Identification of a region of the fibrin molecule involved in upregulation of interleukin-8 expression from human oral squamous cell carcinoma cells

Archives of Oral Biology

Volumn 48, Issue 4, 2003, Pages 263-271

  Lalla, Rajesh V ^a   Tanzer, Marvin L ^a   Kreutzer, Donald L ^b  

^a University of CT Medical Center   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Fibrin; Interleukin 8; Oral cancer

Indexed keywords

EID: 0037392651     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(03)00005-0     Document Type: Article

References (32)

1. Arihiro K, Oda H, Kaneko M, Inai K. Cytokines facilitate chemotactic motility of breast carcinoma cells. Breast Cancer 2000;7(3):221-30.
2. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis [see comments]. Science 1992;258(5089):1798-801.
3. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994;54(12):3242-7.
4. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, et al. Interleukin-8. A corneal factor that induces neovascularisation. Am J Pathol 1992;141(6):1279-84.
5. Bar-Eli M. Role of interleukin-8 in tumour growth and metastasis of human melanoma. Pathobiology 1999;67(1):12-8.
6. Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1995;121(2):202-9.
7. Eisma RJ, Spiro JD, Kreutzer DL. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope 1999;109(5):687-93.
8. Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 1997;174(5):507-12.
9. Lingen MW, Polverini PJ, Bouck NP. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol 1996;149(1):247-58.
10. Costantini V, Zacharski LR. Fibrin and cancer. Thromb Haemost 1993;69(5):406-14.
11. Costantini V, Zacharski LR. The role of fibrin in tumour metastasis. Cancer Metastasis Rev 1992;11(3-4):283-90.
12. Qi J, Goralnick S, Kreutzer DL. Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells. Blood 1997a;90(9):3595-602.
13. Qi J, Kreutzer DL, Piela-Smith TH. Fibrin induction of ICAM-1 expression in human vascular endothelial cells. J Immunol 1997;158(4):1880-6.
14. Lalla RV, Spiro JD, Tanzer ML, Kreutzer DL. Association of fibrin and interleukin-8 in human oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 [in press].
15. Lalla RV, Goralnick SJ, Tanzer ML, Kreutzer DL. Fibrin induces IL-8 expression from human oral squamous cell carcinoma cells. Oral Oncol 2001;37(3):234-42.
16. Harley SL, Sturge J, Powell JT. Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. Arterioscler Thromb Vasc Biol 2000;20(3):652-8.
17. Rheinwald JG, Beckett MA. Tumourigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981;41(5):1657-63.
18. Kudryk B, Rohoza A, Ahadi M, Chin J, Wiebe ME. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol 1984;21(1):89-94.
19. Dvorak HF. Tumours: wounds that do not heal. Similarities between tumour stroma generation and wound healing. New Engl J Med 1986;315(26):1650-9.
20. Dvorak HF, Harvey VS, McDonagh J. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Res 1984;44(8):3348-54.
21. Brown LF, Dvorak AM, Dvorak HF. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumours and to many other types of disease. Am Rev Respir Dis 1989;140(4):1104-7.
22. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumour stroma generation and wound healing. Lab Invest 1987;57(6):673-86.
23. Kosugi T, Takagi I, Ariga Y, Okada S, Morimitsu T, Mihara H. Fibrinolysis-coagulation system in patients with cancer of the head and neck. Preliminary report. Arch Otorhinolaryngol 1982;236(3):211-5.
24. Zacharski LR, Meehan KR, Algarra SM, Calvo FA. Clinical trials with anticoagulant and antiplatelet therapies. Cancer Metastasis Rev 1992;11(3-4):421-31.
25. Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial [see comments]. New Engl J Med 2000;342(26):1953-8.
26. Liu X, Piela-Smith TH. Fibrin(ogen)-induced expression of ICAM-1 and chemokines in human synovial fibroblasts. J Immunol 2000;165(9):5255-61.
27. Ghosh M, Aroor AR, Raghavan MR. Clinical utility of serum fibrinogen degradation products (FDP) in the diagnostic and prognostic evaluation of oral cancer. Ann Dent 1990;49(2):11-12, 45.
28. Schlager SI, Dray S. Complete local tumour regression with antibody to fibrin fragment E. J Immunol 1975;115(4):976-81.
29. Bourdon MA, Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 1989;108(3):1149-55.
30. Yamaguchi T, Yamamoto Y, Yokota S, Nakagawa M, Ito M, Ogura T. Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Jpn J Clin Oncol 1998;28(12):740-4.
31. Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 1998;186(1):8-16.
32. De Bruin A, Muller E, Wurm S, Caldelari R, Wyder M, Wheelock MJ. Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. Cell Adhes Commun 1999;7(1):13-28.